Compounded tirzepatide
boostAGErx vs Fifty 410
Quick answer
Fifty 410 costs $133 a real month and boostAGErx costs $145 — a difference of $12 a month, or $144 a year. Both figures are computed from what each seller actually charges and how often, not from the price on its landing page.
What each one bills
| boostAGErx | Fifty 410 | |
|---|---|---|
| True monthly cost | $145 | $133 |
| Advertised as | $145 | $133 |
| Charged | every calendar month | every 3 months |
| Each charge | $145 | $399 |
| Price basis | not stated | a starting-dose price that climbs |
| Mandatory recurring fee | none found | none found |
| States it names | not published | not published |
| FDA warning letter | none on record | yes |
Where they actually differ
- They bill on different clocks. boostAGErx charges every calendar month and Fifty 410 charges every 3 months. That alone changes what a “month” costs, which is the whole reason this index recomputes every price.
- One price holds and the other climbs. boostAGErx’s price is not stated; Fifty 410’s is a starting-dose price that climbs. See what titration does to an advertised figure.
How we know
Both figures were read on the seller’s own site and recomputed over a 30.4375-day calendar month from the charge and the billing period it covers. Neither is a seller’s own “/mo”. The full working for each — the charge, the period, the arithmetic and the date it was read — is on its own page: boostAGErx and Fifty 410. The method is set out in how we verify.
To compare any two sellers in the index rather than these two, use the comparison tool.